Skip to content

International Journal of Drug Policy

ISSN 1873-4758, 0955-3959

82 papers in the library · 1,858 citations · publishing 2006-2026

Papers

Sort Most recent Most cited

'Surfing the Silk Road': a study of users' experiences.

International Journal of Drug Policy November 1, 2013 Marie Claire Van Hout, Tim Bingham 211 citations

The online drug marketplace called 'Silk Road' has operated anonymously on the 'Deep Web' since 2011. It is accessible through computer encrypting software (Tor) and is supported by online transactions using peer to peer anonymous and untraceable crypto-currency (Bit Coins). The study aimed to describe user motives and realities of accessing, navigating and purchasing on the 'Silk Road'...

DOI: 10.1016/j.drugpo.2013.08.011 (opens in new tab) Full text (opens in new tab) Closed drug markets Displacement patterns Silk road Online drug markets +8

Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida's ban.

International Journal of Drug Policy November 1, 2012 John Stogner, David N Khey, O Hayden Griffin et al. 31 citations

A plant with dissociative and psychoactive properties began to attract the attention of the media and United States policymakers following a well-publicized suicide in 2006 and reports that the plant served as a 'legal high' and substitute for cannabis. As a result, Salvia divinorum and its active ingredient, salvinorin A, were classified as Schedule I substances by the Florida Legislature on...

Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.

International Journal of Drug Policy March 2012 Tibor M Brunt, Raymond J.m. Niesink, Wim van den Brink

A recent decline in MDMA-like substances in ecstasy tablets has been reported by a number of countries in the European Union. This study describes the instability of the ecstasy market in The Netherlands during 2008 and 2009, and investigates whether this had any impact on drug testing or patterns of drug use. The health concerns of drug users handing in drug samples at drug testing facilities...

Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges

International Journal of Drug Policy August 19, 2011 Beatriz Caiuby Labate, Kevin Feeney 142 citations

BackgroundThis paper provides a summary and analysis of the regulation of ayahuasca in Brazil, from its prohibition in the mid-eighties to the recent adoption of CONAD's (Conselho Nacional de Políticas sobre Drogas) 2010 Resolution, which established a set of rules, norms and ethical principles to be applied to religious and ritual uses of ayahuasca. Brazil's regulatory process is used as a...

DOI: 10.1016/j.drugpo.2011.06.006 (opens in new tab) Ayahuasca Process computing Process management Anthropology

Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.

International Journal of Drug Policy November 1, 2010 Sarah Riley, James Thompson, Christine Griffin 27 citations

Between 2002 and 2005 fresh or unprepared psilocin-based 'magic' mushrooms were legal to possess and traffic in the UK, and commercial sales demonstrated a significant market for this hallucinogenic drug. During and after this time there has been relatively little analysis concerning how magic mushroom users accounted for their drug use, nor on the wider political and cultural discourses that...

Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin.

International Journal of Drug Policy May 1, 2010 Colin Wark, John F Galliher 12 citations

This research focuses on the events leading to the 1968 U.S. federal prohibition of psilocybin. It is a study of duelling moral entrepreneurs-Timothy Leary and Richard Alpert vs. the Harvard University Administration. The goal is to show how the primary active compound in an ostensibly harmless fungus (the psilocybin mushroom) became controversial in less than a decade. We used books,...

DOI: 10.1016/j.drugpo.2009.08.004 (opens in new tab) Full text (opens in new tab) Psilocybin history Psilocybin criminalization Psilocybin prohibition Psychedelic history +15

The globalization of ayahuasca: Harm reduction or benefit maximization?

International Journal of Drug Policy December 5, 2006 Kenneth W. Tupper 207 citations

Ayahuasca is a tea made from two plants native to the Amazon, Banisteriopsis caapi and Psychotria viridis, which, respectively, contain the psychoactive chemicals harmala alkaloids and dimethyltryptamine. The tea has been used by indigenous peoples in countries such as Brazil, Ecuador and Peru for medicinal, spiritual and cultural purposes since pre-Columbian times. In the 20th century,...

DOI: 10.1016/j.drugpo.2006.11.001 (opens in new tab) Ayahuasca Indigenous Globalization Environmental ethics